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Frogs of the neotropical family Dendrobatidae produce a remarkably 
diverse array of biologically active alkaloids. One of the major 
classes of these amphibian alkaloids[1] are the decahydroquinolines, 
which have been isolated not only from skin extracts of dendrobatid 
and mantelline frogs[2] but also from bufonid toads,[3] tunicates,[4] 
marine flatworms,[4b] and myrmicine ants.[5] They possess either a cis 
or trans decahydroquinoline ring fusion, with a side chain substituent 
at both the C-2 and C-5 positions and, in the lepadin series,[4] an 
acylated hydroxy group at the C-3 position. The most representative 
decahydroquinoline alkaloid is cis-195A (formerly called 
pumiliotoxin C), first isolated in 1969 from a Panamanian population 
of Dendrobates pumilio.[6] 
The source of amphibian alkaloids remains an unresolved and 
challenging question,[1] in particular after the discovery that some of 
these alkaloids also occur in ants, thus strengthening a dietary 
hypothesis for their origin in frogs.[5] Although there are no 
conclusive studies concerning the biosynthesis of these toxins and, 
consequently, little is known about the biosynthetic pathways, there 
has been speculation as to possible derivation from the polyketide 
route by aminocyclization of polycarbonyl intermediates (A), leading 
to either 2,5-disubstituted decahydroquinolines (C) or 
spiropiperidines (histrionicotoxins).[1a,b,7] In accordance with this 
hypothesis, a plausible biosynthetic pathway to the 
decahydroquinoline class of dendrobatid alkaloids is depicted in 
Scheme 1.[8] 
 
 
The structural diversity and pharmacological activity associated 
with this class of alkaloids, as well as the limited amounts available 
from natural sources, have stimulated considerable synthetic effort in 
this area,[9] including some biomimetic approaches.[10] In this context 
we present herein a biomimetic enantioselective approach to the 
decahydroquinoline class of dendrobatid alkaloids, which has 
culminated in the biomimetic synthesis of ()-pumiliotoxin C.[11] 
Our synthetic approach involves the use of an appropriate 1,5-
polycarbonyl derivative as a synthetic equivalent of the hypothetical 
biogenetic polyketide intermediate A and (R)-phenylglycinol as a 
chiral latent form of ammonia to induce the key enantioselective 
biomimetic aminocyclization to the target hydroquinoline system. 
To evaluate the feasibility of our proposal, we initially used 1,5-
tetracarbonyl compound 2 [A: R1 = OEt; R2 = (CH2)3CO2Et], which 
was easily accessible in excellent yield (82%) by reaction of glutaryl 
dichloride with 4-ethoxy-4-oxobutylzinc bromide (1) in the presence 
of Pd(PPh3)4 as the catalyst (Scheme 2). 
To our delight, heating a benzene solution of 2 and (R)-
phenylglycinol under Dean-Stark conditions in the presence of a 
catalytic amount of AcOH, resulted in the straightforward 
construction of the hydroquinoline ring system, with generation of 
two stereogenic centers, leading directly to the enantiopure tricyclic 
lactam 3 in 35% yield. Cyclohexenone 4 (22%) and hydroquinolone 
5 (25% yield; nearly equimolecular mixture of stereoisomers) were 
also isolated. Formation of 3 can be rationalized by considering that, 
after an initial aldol cyclization from the symmetrical starting 
diketone 2, the resulting -oxoester 4 undergoes a phenylglycinol-
promoted cyclocondensation reaction, in a process that mimics the 
proposed biosynthetic pathway depicted in Scheme 1. In accordance 
with this interpretation, 2 was first cyclized to cyclohexenone 4 in 
excellent yield (90%), by treatment with 1N aqueous LiOH followed 
by reesterification, and then converted to lactam 3 (60% yield) by 
reaction with (R)-phenylglycinol in refluxing C6H6-cat AcOH. [12] On 
the other hand, the formation of 5 in the direct reaction of 2 with (R)-
phenylglycinol is a consequence of the initial generation of an 
oxazolidine, which then undergoes two successive cyclizations as 
depicted in Scheme 3. 
By choosing the appropriate 1,5-polycarbonyl derivative, the 
above biomimetic double cyclocondensation can be adapted to the 
enantioselective synthesis of a variety of 2,5-disubstituted 
decahydroquinoline derivatives, as exemplified by the synthesis of 
the decahydroquinoline alkaloid cis-195A outlined in Scheme 4. The 
required diketoester 6 was prepared in 65% yield by Pd-catalyzed 
coupling of 5-oxohexanoyl chloride with the functionalized 
organozinc derivative 1 and stereoselectively converted as in the 
above series to a tricyclic hydroquinolone lactam (8) in excellent 
overall yield. Thus, the initial aldol cyclocondensation took place in 
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85% yield, whereas cyclocondensation of the resulting 
cyclohexenone 7 with R-phenylglycinol led to lactam 8 in 70% yield 
in a process again involving the generation of two stereogenic 
centers from an achiral precursor. [12] In this series the configuration 
of the stereogenic ring fusion carbons generated in this step was 
unambiguously established by X-ray crystallographic analysis[13] of 
perhydroquinoline 9, which was stereoselectively obtained in nearly 
quantitative yield by catalytic hydrogenation of 8. The X-ray 
structure of 9 also made evident the trans relationship between the 
hydrogens at the 4a and 5 positions of the quinoline ring.  
The lactam carbonyl present in tricyclic lactam 9 allows the 
introduction of substituents at the 2-position of the hydroquinoline 
ring, ultimately leading to enantiopure 2,5-disubstituted cis-
perhydroquinolines. Thus, 9 was converted to the corresponding 
thioamide, which was then subjected to Eschenmoser sulfide 
contraction[14] conditions (BrCH2CO2Me, CHCl3; then (MeO)3P, 
Et3N, CHCl3, reflux) to give -enamino ester 10 in 50% overall yield. 
At this point the complete relative stereochemistry of the target 
alkaloid cis-195A (pumiliotoxin C) was installed by hydrogenation 
of 10 in the presence of PtO2 under acidic conditions, which brought 
about both the stereoselective reduction of the vinylogous urethane 
double bond and cleavage of the oxazolidine C-O bond. A 
subsequent debenzylation with hydrogen and Pd(OH)2 in the 
presence of Boc2O led to the protected cis-perhydroquinoline 11. 
Finally, the conversion of ester 11 to pumiliotoxin C was 
accomplished in satisfactory overall yield by reduction to alcohol 12, 
followed by methylenation of the corresponding aldehyde, 
subsequent catalytic hydrogenation of the resulting N-Boc-2-
allylperhydroquinoline, and finally deprotection of the piperidine 
nitrogen. The NMR data and []D22 value (15.3, c = 0.5 in MeOH) 
of cis-195A (pumiliotoxin C) hydrochloride were coincident with 
those reported in the literature.[11] 
The above results significantly expand the scope and potential of 
phenylglycinol-derived oxazolopiperidone lactams as chiral building 
blocks for the enantioselective synthesis of complex piperidine-
containing derivatives.[15] These lactams are easily accessible by a 
cyclocondensation reaction of a -oxoacid derivative with 
phenylglycinol. The use of diketo(di)esters 2 and 6 as the -oxoester 
partners in the cyclocondensation reactions reported herein allows 
the straightforward construction of the hydroquinoline ring system. 
These 1,5-polycarbonyl derivatives mimic the biogenetic 
intermediates A (Scheme 1) by undergoing a biomimetic double 
cyclization that reproduces the key step of the biosynthesis of the 
decahydroquinoline class of dendrobatid alkaloids. 
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Scheme 1. A hypothetical biosynthetic pathway to the 
decahydroquinoline class of dendrobatid alkaloids. 
Scheme 2. Biomimetic construction of the hydroquinoline ring system. 
Scheme 3. Plausible mechanism for the formation of 5. 
Scheme 4. Biomimetic synthesis of decahydroquinoline cis-195A [()-
Pumiliotoxin C]. 
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